Radioisotope manufacturer International Isotopes of Denton, TX, reported last month that the Texas Department of Public Health's Bureau of Radiation Control has approved a license amendment for the production of small quantities of thallium-201, a
Radioisotope manufacturer International Isotopes of Denton, TX, reported last month that the Texas Department of Public Health's Bureau of Radiation Control has approved a license amendment for the production of small quantities of thallium-201, a radioisotope used for the diagnosis of heart disease and cardiac function. The isotope will be manufactured using International Isotopes' linear accelerator, as well as its cyclotron.
The approval allows the firm to begin preliminary shipments of thallium and other radiochemicals to pharmaceutical companies, a crucial step in establishing itself as a reliable provider of raw pharmaceutical material, according to Carl Seidel, president and CEO. International Isotopes will begin shipping thallium in early March, but declined to name particular customers.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.